References

2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines

10.1161/cir.0000000000001193 · 2024 · External reference

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

10.1161/cir.0000000000001123 · 2023 · External reference

Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study

10.1161/circulationaha.113.005119 · 2014 · External reference

Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium

10.1161/jaha.112.000102 · 2013 · External reference

A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham heart study

10.1016/j.ahj.2016.05.004 · 2016 · External reference

N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the cardiovascular health study

10.1161/circulationaha.109.873265 · 2009 · External reference

N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the multi-ethnic study of atherosclerosis: the effects of age, sex and ethnicity

10.1136/heartjnl-2013-304724 · 2013 · External reference

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

10.1161/circulationaha.109.882241 · 2010 · External reference

Association between NT-proBNP levels and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

10.1136/heartjnl-2024-324685 · 2025 · External reference

Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation

10.1016/j.ahj.2013.10.003 · 2014 · External reference

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the atherosclerosis risk in communities (ARIC) study

10.1016/j.ahj.2014.10.005 · 2015 · External reference

Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults

10.1016/j.hrthm.2015.01.020 · 2015 · External reference

Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?

10.1161/circulationaha.112.112920 · 2012 · External reference

Cardiac ketone body metabolism

10.1016/j.bbadis.2020.165739 · 2020 · External reference

Multi-ethnic study of atherosclerosis: objectives and design

10.1093/aje/kwf113 · 2002 · External reference

A new equation to estimate glomerular filtration rate

10.7326/0003-4819-150-9-200905050-00006 · 2009 · External reference

Ketone bodies are mildly elevated in subjects with type 2 diabetes mellitus and are inversely associated with insulin resistance as measured by the lipoprotein insulin resistance index

10.3390/jcm9020321 · 2020 · External reference

N-terminal pro B-type natriuretic peptide and high-sensitivity cardiac troponin as markers for heart failure and cardiovascular disease risks according to glucose status (from the multi-ethnic study of atherosclerosis [MESA])

10.1016/j.amjcard.2020.01.025 · 2020 · External reference

Pericardial fat volume and incident atrial fibrillation in the multi-ethnic study of atherosclerosis and Jackson heart study

10.1002/oby.21835 · 2017 · External reference

10.1093/eurheartj/ehab368

10.1093/eurheartj/ehab368 · 2021 · External reference

Analytical validation of a high-sensitivity cardiac troponin T assay

10.1373/clinchem.2009.132654 · 2010 · External reference

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE trial (Apixaban for the prevention of stroke in subjects with atrial fibrillation)

10.1016/j.jacc.2012.11.082 · 2013 · External reference

Proteomic signatures for risk prediction of atrial fibrillation

10.1161/circulationaha.124.073457 · 2025 · External reference

Utilization of serum metabolomics and polygenic risk scores in a novel risk stratification tool for the prediction of incident atrial fibrillation

10.1161/circep.125.013858 · 2026 · External reference

Ketones and the cardiovascular system

10.1038/s44161-023-00259-1 · 2023 · External reference

Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes

10.1161/circresaha.113.302095 · 2013 · External reference

Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects

10.1093/eurjpc/zwae306 · 2025 · External reference

Fuelling biomarker discovery in atrial fibrillation: a case for ketone bodies?

10.1093/eurjpc/zwaf648 · 2025 · External reference

The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients

10.1038/hr.2009.41 · 2009 · External reference

Circulating ketone bodies and risk of incident atrial fibrillation: insights from the MESA and UK biobank cohorts

10.1093/eurjpc/zwaf543 · 2025 · External reference

2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

10.1093/eurheartj/ehae176 · 2024 · External reference

Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: a meta-analysis of randomized controlled trials

10.1016/j.metabol.2025.156463 · 2026 · External reference

Criteria to assess the predictive and clinical utility of novel models, biomarkers, and tools for risk of cardiovascular disease: a scientific statement from the American Heart Association

10.1161/cir.0000000000001401 · 2026 · External reference

The ketogenic diet through a metabolomic lens: biochemical pathways, therapeutic applications, and analytical challenges

10.3390/nu17182969 · 2025 · External reference